Clinical Trials Browser

Active not recruiting × Nasopharyngeal Carcinoma × camrelizumab × Clear all

NCT05524168 2026-01-15

SBRT Combined With PD-1 Antibody and Chemotherapy in Oligometastatic Nasopharyngeal Carcinoma

Phase 2 Active not recruiting

Nasopharyngeal Carcinoma